Jose Carlos Sadalla
Overview
Explore the profile of Jose Carlos Sadalla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simonsen M, Mendoza Lopez R, Maistro S, Ikeoka L, Pereira G, Lugao A, et al.
Front Oncol
. 2025 Jan;
14():1487376.
PMID: 39845320
Introduction: Intraperitoneal chemotherapy for ovarian cancer treatment has controversial benefits as most methodologies are associated with significant morbidity. We carried out a systematic review to compare tumor response, measured by...
2.
Ingold C, Navarro P, de Oliveira R, Barbosa C, Sadalla J, Bedoschi G
Front Reprod Health
. 2024 Jan;
5:1295939.
PMID: 38260048
Introduction: Oocyte cryopreservation is an established technique for fertility preservation in women diagnosed with cancer. However, some clinical scenarios may preclude the commonly used transvaginal approach to oocyte retrieval. In...
3.
Hase E, Shinohara H, Alves Filho J, Sadalla J, Ab Saber A, Francisco R
Front Med (Lausanne)
. 2023 Apr;
10:1138447.
PMID: 37064023
The incidence of ovarian cancer during pregnancy is low. Most adnexal tumors removed during pregnancy are benign, with ovarian carcinomas found in approximately 1: 10,000-1: 50,000 pregnancies. Literature on this...
4.
Maluf F, Zibetti G, Paulino E, de Melo A, Racy D, Ferrigno R, et al.
Front Oncol
. 2022 Oct;
12:928568.
PMID: 36203438
Introduction: Due to scant literature and the absence of high-level evidence, the treatment of vulvar cancer is even more challenging in countries facing limited resources, where direct application of international...
5.
Maluf F, Molin G, de Melo A, Paulino E, Racy D, Ferrigno R, et al.
Front Oncol
. 2022 Sep;
12:928560.
PMID: 36059643
Introduction: Nearly 85% of cervical cancer new cases are diagnosed in limited resources countries. Although several strategies have been proposed to reduce the disease burden, challenges remain to provide the...
6.
Genta M, Martins T, Mendoza Lopez R, Sadalla J, Mancusi de Carvalho J, Baracat E, et al.
PLoS One
. 2017 Aug;
12(8):e0182854.
PMID: 28829791
Background: Invasive cervical cancer (ICC) is the third most common malignant neoplasm affecting Brazilian women. Little is known about the impact of specific HPV genotypes in the prognosis of ICC....
7.
Sadalla J, de Andrade J, Genta M, Baracat E
Rev Assoc Med Bras (1992)
. 2016 Feb;
61(6):536-42.
PMID: 26841164
Cervical cancer is the most common gynecological cancer in Brazil. Among women, it is the second most frequent, second only to breast cancer. It is the fourth leading cause of...
8.
Sadalla J, Lourenco S, Sotto M, Baracat E, Carvalho J
J Clin Pathol
. 2011 Jun;
64(10):853-7.
PMID: 21642657
Aims: Vulvar squamous-cell carcinoma (SCC) is a rare gynaecological cancer. Vulvar SCC has been shown to develop from vulvar intraepithelial neoplasias, which are related to lichen sclerosus (LS). Most studies...